Roger Klein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roger Klein has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Chan Shen
Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA
1 shared publication - Douglas L. Leslie
Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA
1 shared publication Francis Vella
Georgetown University, Department of Economics, 37th and O Streets, NW, Washington DC, 20057 USA
1 shared publication- Francis Vella
Georgetown Universisty, Washington, USA
1 shared publication - James Douglas Thornton
Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX 77204, USA
1 shared publication - Lídia Farré
Institut d'Anàlisi Econòmica, Campus UAB 08193, Bellaterra, Spain
1 shared publication
Latest Publications
- Open Access
- 23 October 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (11) , 593
Effects of Hydrocodone Rescheduling on Pain Management Practices Among Older Breast Cancer Patients
Hydrocodone, a commonly prescribed opioid, was rescheduled from Schedule III to Schedule II in October 2014, imposing stricter prescribing regulations. While prior studies have examined its effects in general populations, its impact on breast cancer patients remains unclear. We evaluated changes in pain management among older women with early-stage breast cancer following this policy change. Using SEER-Medicare data from 2011–2019, we identified a retrospective cohort of 52,792 women aged ≥66 years. We assessed trends in the use of hydrocodone, non-hydrocodone opioids, NSAIDs, and antidepressants before and after rescheduling. Hydrocodone use declined from 55% to 40%, while non-hydrocodone opioid use increased from 43% to 50%. Multivariable logistic regression adjusted for demographic and clinical factors confirmed a significant decrease in hydrocodone use (AOR: 0.81, 95% CI: 0.75–0.86) and an increase in non-hydrocodone opioid use (AOR: 1.25, 95% CI: 1.21–1.30). Hydrocodone dosage also declined, while non-hydrocodone opioid dosages remained stable. No significant changes were observed in NSAID or antidepressant use. These findings suggest that hydrocodone rescheduling significantly altered opioid prescribing patterns, reducing hydrocodone use and prompting a shift toward alternative opioids. Further research is warranted to evaluate the appropriateness and outcomes of such shifts in cancer pain management.
- 23 October 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (11) , 593
Open AccessEffects of Hydrocodone Rescheduling on Pain Management Practices Among Older Breast Cancer Patients
Hydrocodone, a commonly prescribed opioid, was rescheduled from Schedule III to Schedule II in October 2014, imposing stricter prescribing regulations. While prior studies have examined its effects in general populations, its impact on breast cancer patients remains unclear. We evaluated changes in pain management among older women with early-stage breast cancer following this policy change. Using SEER-Medicare data from 2011–2019, we identified a retrospective cohort of 52,792 women aged ≥66 years. We assessed trends in the use of hydrocodone, non-hydrocodone opioids, NSAIDs, and antidepressants before and after rescheduling. Hydrocodone use declined from 55% to 40%, while non-hydrocodone opioid use increased from 43% to 50%. Multivariable logistic regression adjusted for demographic and clinical factors confirmed a significant decrease in hydrocodone use (AOR: 0.81, 95% CI: 0.75–0.86) and an increase in non-hydrocodone opioid use (AOR: 1.25, 95% CI: 1.21–1.30). Hydrocodone dosage also declined, while non-hydrocodone opioid dosages remained stable. No significant changes were observed in NSAID or antidepressant use. These findings suggest that hydrocodone rescheduling significantly altered opioid prescribing patterns, reducing hydrocodone use and prompting a shift toward alternative opioids. Further research is warranted to evaluate the appropriateness and outcomes of such shifts in cancer pain management.
- 6 September 2011
- Published by Wiley in Oxford Bulletin of Economics and Statistics
- Vol. 74 (5) , 676-690
Does Increasing Parents’ Schooling Raise the Schooling of the Next Generation? Evidence Based on Conditional Second Moments*
- 6 September 2011
- Published by Wiley in Oxford Bulletin of Economics and Statistics
- Vol. 74 (5) , 676-690
Does Increasing Parents’ Schooling Raise the Schooling of the Next Generation? Evidence Based on Conditional Second Moments*
- 13 June 2010
- Published by Springer Nature in Empirical Economics
- Vol. 44 (1) , 111-133
A parametric control function approach to estimating the returns to schooling in the absence of exclusion restrictions: an application to the NLSY
- 13 June 2010
- Published by Springer Nature in Empirical Economics
- Vol. 44 (1) , 111-133
A parametric control function approach to estimating the returns to schooling in the absence of exclusion restrictions: an application to the NLSY
- 1 March 2002
- Published by The Econometric Society in Econometrica
- Vol. 70 (2) , 663-691
Shift Restrictions and Semiparametric Estimation in Ordered Response Models
- 1 March 2002
- Published by The Econometric Society in Econometrica
- Vol. 70 (2) , 663-691
Shift Restrictions and Semiparametric Estimation in Ordered Response Models